1. Staphylococcus epidermidis and other coagulase-negative staphylococci;Archer,1995
2. Antimicrobial susceptibility of coagulase-negative staphylococci;Archer;Antimicrob Agents Chemother,1994
3. Conjugative transfer genes in staphylococcal isolates from the United States;Archer;Antimicrob Agents Chemother,1991
4. Comparison of the antibacterial activities of the quinolones Bay 12–8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin;Bauernfeind;J Antimicrob Chemother,1997
5. Birmingham MC, Zimmer GS, Hafkin B, et al: Outcomes with linezolid (LZD) from an ongoing compassionate use (CU) trials of patients (Pts) with significant, resistant, gram-positive infections [abstr 1098]. In Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, 1999, p 724